NEW YORK, Oct. 11, 2016 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of St. Jude Medical Inc. ("St. Jude" or the "Company") (NYSE: STJ) (ISIN: US7908491035). Investors are advised to contact Robert S. Willoughby at rswilloughby@pomlaw.com or 888-476-6529, ext. 9980.
The investigation concerns whether St. Jude and certain of its officers and/or directors have violated the federal securities laws.
Click here to join a class action
On October 11, 2016, pre-market, St. Jude issued a letter to physicians and patients warning that batteries on thousands of the Company's implantable defibrillators can quickly and unexpectedly deplete. The Company stated that two people had died after their devices failed to work correctly because of the drained battery, while 47 others reported dizziness or fainting. The warning applies to devices made before May 2015, which are in use by roughly 350,000 people worldwide.
On this news, St. Jude stock has fallen as much as $2.76, or 3.4%, during intraday trading on October 11, 2016.
The Pomerantz Firm, with offices in New York, Chicago, Florida, and Los Angeles, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L.. Pomerantz, known as the dean of the class action bar, the Pomerantz Firm pioneered the field of securities class actions. Today, more than 80 years later, the Pomerantz Firm continues in the tradition he established, fighting for the rights of the victims of securities fraud, breaches of fiduciary duty, and corporate misconduct. The Firm has recovered numerous multimillion-dollar damages awards on behalf of class members. See www.pomerantzlaw.com
Robert Willoughby
Investor Relations Manager
Pomerantz LLP
600 Third Avenue, 20th Floor
New York, NY 10016
Tel. 212.661.1100, ext. 9980
Fax 646-355-0083
www.pomlaw.com
rswilloughby@pomlaw.com
This email and any attachments thereto, is intended only for use by the addressee(s) named herein and may contain legally privileged and/or confidential information. If you are not the intended recipient of this email, you are hereby notified any dissemination, distribution or copying of this email, and any attachments thereto, is strictly prohibited. If you receive this email in error please immediately notify me at (212) 661-1100 and permanently delete all copies of the email and any attachments.
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/shareholder-alert-pomerantz-law-firm-investigates-claims-on-behalf-of-investors-of-st-jude-medical-inc---stj-300342702.html
SOURCE Pomerantz LLP
